Ignite Creation Date:
2024-05-06 @ 3:47 PM
Last Modification Date:
2024-10-26 @ 1:56 PM
Study NCT ID:
NCT04751487
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-07-12
First Post:
2021-02-08
Brief Title:
Study to Assess the Efficacy Safety and Tolerability of SAR440340REGN3500Itepekimab in Chronic Obstructive Pulmonary Disease COPD
Sponsor:
Sanofi
Organization:
Sanofi
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Chronic Obstructive Pulmonary Disease |
Keywords: